ULTRAHUMAN ONE LTD has a total of 14 patent applications. It increased the IP activity by 900.0%. Its first patent ever was published in 2017. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets biotechnology and pharmaceuticals are PEPMAB B V, VIELA BIO INC and INST OF PRECLINICAL MEDICINE C.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 2 | |
#2 | United States | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | United Kingdom | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | Singapore | 1 | |
#12 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Finlay William James Jonathan | 10 |
#2 | William James Jonathan Finlay | 2 |
Publication | Filing date | Title |
---|---|---|
EP3759137A1 | Csf1r binding agents | |
SG11201906963QA | Binding agents | |
GB201713296D0 | Binding agents |